Newsroom

YSOPIA Bioscience secures €1.55M in non-dilutive funding from Bpifrance and the European Regional...

Nov 17, 2020

La société innovante bordelaise LNC Therapeutics devient Ysopia Bioscience

Oct 2, 2020

LNC Therapeutics becomes YSOPIA Bioscience marking its transition to a clinical stage company

Sep 29, 2020

LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial...

Sep 14, 2020

LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial...

Sep 8, 2020

Discovering the Therapeutic Potential of Keystone Bacteria in Treating Chronic Diseases

Apr 22, 2020